156 related articles for article (PubMed ID: 21530486)
1. The role of Phe329 in binding of cationic triarylmethane dyes to human butyrylcholinesterase.
Biberoglu K; Tacal Ö; Akbulut H
Arch Biochem Biophys; 2011 Jul; 511(1-2):64-8. PubMed ID: 21530486
[TBL] [Abstract][Full Text] [Related]
2. Determination of binding points of methylene blue and cationic phenoxazine dyes on human butyrylcholinesterase.
Sezgin Z; Biberoglu K; Chupakhin V; Makhaeva GF; Tacal O
Arch Biochem Biophys; 2013 Apr; 532(1):32-8. PubMed ID: 23353050
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human plasma cholinesterase by malachite green and related triarylmethane dyes: mechanistic implications.
Küçükkilinç T; Ozer I
Arch Biochem Biophys; 2005 Aug; 440(2):118-22. PubMed ID: 16036213
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of cationic triarylmethane, phenoxazine and phenothiazine dyes on horse serum butyrylcholinesterase.
Yücel YY; Tacal O; Ozer I
Arch Biochem Biophys; 2008 Oct; 478(2):201-5. PubMed ID: 18656440
[TBL] [Abstract][Full Text] [Related]
5. Adduct-forming tendencies of cationic triarylmethane dyes with proteins: metabolic and toxicological implications.
Tacal O; Ozer I
J Biochem Mol Toxicol; 2004; 18(5):253-6. PubMed ID: 15549706
[TBL] [Abstract][Full Text] [Related]
6. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
Bosak A; Gazić I; Vinković V; Kovarik Z
Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
[TBL] [Abstract][Full Text] [Related]
7. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
[TBL] [Abstract][Full Text] [Related]
8. Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity.
Duysen EG; Bartels CF; Lockridge O
J Pharmacol Exp Ther; 2002 Aug; 302(2):751-8. PubMed ID: 12130740
[TBL] [Abstract][Full Text] [Related]
9. Expression of three naturally occurring genetic variants (G75R, E90D, I99M) of the BCHE gene of human butyrylcholinesterase.
Mikami LR; Wieseler S; Souza RL; Schopfer LM; Lockridge O; Chautard-Freire-Maia EA
Pharmacogenet Genomics; 2007 Sep; 17(9):681-5. PubMed ID: 17700357
[TBL] [Abstract][Full Text] [Related]
10. Multi-site inhibition of human plasma cholinesterase by cationic phenoxazine and phenothiazine dyes.
Küçükkilinç T; Ozer I
Arch Biochem Biophys; 2007 May; 461(2):294-8. PubMed ID: 17428437
[TBL] [Abstract][Full Text] [Related]
11. Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase: synergy results in a somanase.
Millard CB; Lockridge O; Broomfield CA
Biochemistry; 1998 Jan; 37(1):237-47. PubMed ID: 9425044
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cholinesterases by safranin O: Integration of inhibition kinetics with molecular docking simulations.
Onder S; Sari S; Tacal O
Arch Biochem Biophys; 2021 Feb; 698():108728. PubMed ID: 33345803
[TBL] [Abstract][Full Text] [Related]
14. Specificity of ethephon as a butyrylcholinesterase inhibitor and phosphorylating agent.
Haux JE; Lockridge O; Casida JE
Chem Res Toxicol; 2002 Dec; 15(12):1527-33. PubMed ID: 12482234
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of electric eel acetylcholinesterase by triarylmethane dyes.
Kuçukkilinç TT; Ozer I
Chem Biol Interact; 2008 Sep; 175(1-3):309-11. PubMed ID: 18571634
[TBL] [Abstract][Full Text] [Related]
16. Five new naturally occurring mutations of the BCHE gene and frequencies of 12 butyrylcholinesterase alleles in a Brazilian population.
Mikami LR; Wieseler S; Souza RL; Schopfer LM; Nachon F; Lockridge O; Chautard-Freire-Maia EA
Pharmacogenet Genomics; 2008 Mar; 18(3):213-8. PubMed ID: 18300943
[TBL] [Abstract][Full Text] [Related]
17. Toluidine blue O is a potent inhibitor of human cholinesterases.
Biberoglu K; Tek MY; Ghasemi ST; Tacal O
Arch Biochem Biophys; 2016 Aug; 604():57-62. PubMed ID: 27296777
[TBL] [Abstract][Full Text] [Related]
18. Hydration change during the aging of phosphorylated human butyrylcholinesterase: importance of residues aspartate-70 and glutamate-197 in the water network as probed by hydrostatic and osmotic pressures.
Masson P; Cléry C; Guerra P; Redslob A; Albaret C; Fortier PL
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):361-9. PubMed ID: 10510301
[TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of effector modulation of butyrylcholinesterase-catalysed hydrolysis of acetanilides and homologous esters.
Masson P; Froment MT; Gillon E; Nachon F; Lockridge O; Schopfer LM
FEBS J; 2008 May; 275(10):2617-31. PubMed ID: 18422653
[TBL] [Abstract][Full Text] [Related]
20. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
Komloova M; Musilek K; Horova A; Holas O; Dohnal V; Gunn-Moore F; Kuca K
Bioorg Med Chem Lett; 2011 Apr; 21(8):2505-9. PubMed ID: 21397501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]